Cargando…
Bromfenac 0.09% for the Treatment of Macular Edema Secondary to Noninfectious Uveitis
PURPOSE: The topical nonsteroidal anti-inflammatory drug bromfenac 0.09% has a potential benefit in uveitic macular edema (UME) with a safe side effect profile. The aim of the study is to assess the efficacy of bromfenac sodium solution in the treatment of UME. METHODS: The charts of 10 patients wit...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547661/ https://www.ncbi.nlm.nih.gov/pubmed/34759667 http://dx.doi.org/10.4103/meajo.meajo_134_21 |